These findings of a 1.4‐fold enrichment of CFTR PVs in patients with gastrointestinal cancers is consistent with cancer risk in people with CF as data indicate that colorectal cancer incidence is up to 10 times greater and occurring at a younger age in people with CF as compared to the general population [3]. This evidence concerns the gene CFTR and cancer.